Intuitive Surgical

Intuitive Surgical Competitive Intelligence & Landscape

intuitive.com ·

Overview

Intuitive Surgical Overview

Intuitive Surgical (intuitive.com) is a global technology leader and pioneer in robotic-assisted, minimally invasive surgery, founded in 1995 [https://www.intuitive.com/en-us/about-us/company/history]. The company's mission is to make surgery more effective, less invasive, and easier on surgeons, patients, and their families [https://isrg.intuitive.com/]. They advance minimally invasive care by helping physicians and their teams optimize care delivery to support the best possible outcomes [https://www.intuitive.com/en-us/about-us/company].

Intuitive Surgical develops, manufactures, and markets innovative products such as the da Vinci surgical system, including the Da Vinci 5 and Da Vinci SP platforms [https://intuitive.com/], as well as the Ion robotic bronchoscopy system for advancing lung cancer care with minimally invasive biopsies [https://intuitive.com/]. Beyond robotic systems, they also generate data to unlock insights benefiting care systems worldwide [https://www.intuitive.com/en-us/about-us/company].

The company targets a global market of healthcare providers and surgical teams, striving to improve patient care, enhance efficiencies, and broaden access to quality healthcare [https://www.intuitive.com/en-us/about-us/company/history]. Headquartered in Sunnyvale, California [https://www.intuitive.com/en-us/about-us/contact/office-locations], Intuitive Surgical has grown significantly, employing over 20,000 individuals dedicated to building the future of minimally invasive care [https://careers.intuitive.com/en/who-we-are/].

Intuitive Surgical

Intuitive Surgical Weekly Intel Updates

Receive weekly intel updates about Intuitive Surgical straight to your inbox.

Competitors

Intuitive Surgical Competitors

While Intuitive Surgical (intuitive.com) leads the robotic-assisted surgery market with its da Vinci and Ion systems, it faces growing competition from established medical device giants and specialized technology companies [https://www.hudson-labs.com/research/intuitive-surgical-competitors-isrg-peers-2026].

Medtronic, a global healthcare technology company, entered the robotic-assisted surgery market with its Hugo robotic-assisted surgery platform, which received FDA approval for urologic procedures in December 2025 [https://www.fool.com/investing/2026/06/08/can-medtronic-finally-challenge-intuitive-surgical/]. This move positions Medtronic as a direct challenger to Intuitive Surgical in an industry Intuitive pioneered [https://www.fool.com/investing/2026/06/08/can-medtronic-finally-challenge-intuitive-surgical/].

Stryker is another significant competitor, known for acquiring MAKO Surgical to bolster its presence in robotic surgery [https://idataresearch.com/top-robotic-surgery-companies-in-the-united-states/].

Stryker's strategy involves integrating robotics into various surgical procedures, offering an alternative to Intuitive Surgical's offerings, particularly in orthopedic and other specialized surgeries [https://idataresearch.com/top-robotic-surgery-companies-in-the-united-states/].

Johnson & Johnson is actively expanding its robotic surgery solutions, with developments such as the DePuy robotic solutions in China for spine and trauma procedures and its acquisition of Auris Medical Technologies [https://idataresearch.com/top-robotic-surgery-companies-in-the-united-states/].

Johnson & Johnson leverages its broad healthcare portfolio to compete across various surgical specialties, challenging Intuitive Surgical's market dominance through diverse robotic platforms [https://idataresearch.com/top-robotic-surgery-companies-in-the-united-states/].

Smith & Nephew also features prominently in the competitive landscape for robotic surgery [https://idataresearch.com/top-robotic-surgery-companies-in-the-united-states/]. While Intuitive Surgical focuses on soft tissue robotic surgery, companies like Smith & Nephew are actively developing and promoting their own robotic solutions, often targeting specific areas like orthopedics, to carve out their market share [http://www.modernhealthcare.com/medical-devices/mh-intuitive-surgical-soft-tissue-robotic-surgery/].

Product & Pricing

Intuitive Surgical Product and Pricing Intelligence

Intuitive Surgical (intuitive.com) offers a range of products and services, primarily centered around its da Vinci robotic surgical systems [https://www.intuitive.com/en-us/products-and-services/da-vinci]. While specific pricing plans for the da Vinci systems are not publicly detailed, the company provides flexible acquisition models, including in-house financing, to help hospitals acquire their surgical systems [https://www.intuitive.com/en-gb/-/media/ISI/Intuitive/Pdf/Flexible-Acquisition-Model-FAM-Booklet.pdf]. This allows for customized financing solutions to meet current and future needs.

A recent pricing change or acquisition model introduced by Intuitive Surgical is the Accelerated MIS program (AMP) [https://www.intuitive.com/en-us/-/media/ISI/Intuitive/Pdf/Accelerated-MIS-program-AMP-One-Pager.pdf]. AMP is a pay-per-use, flexible acquisition model designed for hospitals with tighter capital budgets. It aims to expand access to da Vinci surgery by offering premium robotic system technology without significant upfront costs, addressing barriers and legacy investing habits.

For support and maintenance, Intuitive Surgical provides different care plans for its da Vinci systems. These include da Vinci Premium Care for high-volume surgery programs and da Vinci Essential Care for lower-volume programs, with specific details of what's included in each plan [https://www.intuitive.com/en-us/products-and-services/da-vinci/services]. Additionally, the OnSite program offers 24/7 service with a high uptime guarantee and proactive monitoring [https://www.intuitive.com/en-us/-/media/ISI/Intuitive/Pdf/Da-Vinci-Total-Cost-to-Treat.pdf].

Intuitive Surgical also provides digital solutions through its My Intuitive platform (my.intuitive.com) [https://my.intuitive.com/]. This secure platform offers clinical data and performance insights, learning tools, and performance dashboards for surgeons, pulmonologists, and care teams [https://www.intuitive.com/en-us/digital-solutions/my-intuitive]. While My Intuitive itself appears to be a free platform for users to manage scheduling, inventory, and access reports [https://www.intuitive.com/en-us/-/media/ISI/Intuitive/Pdf/My-Intuitive-Customer-Portal.pdf], an enhanced version called My Intuitive+ is available.

My Intuitive+ can enhance robotic-assisted surgery programs with AI-powered video analysis, real-time surgical collaboration, and console-integrated simulation, and is exclusively available with the da Vinci 5 system [https://www.intuitive.com/en-us/digital-solutions/my-intuitive/my-intuitive-plus].

Hiring & Layoffs

Intuitive Surgical Hiring and Layoffs

Intuitive Surgical (intuitive.com) is actively engaged in hiring, presenting hundreds of job opportunities across various departments, indicating a consistent growth trajectory and a strategic focus on expanding its workforce [https://careers.intuitive.com/en/jobs/]. The company emphasizes recruiting "mission-oriented problem solvers" who are eager to build careers at the intersection of healthcare and technology [https://careers.intuitive.com/en/]. This approach highlights Intuitive Surgical's commitment to innovation and advancing its robotic-assisted surgical systems.

Recent job postings showcase a strong demand for engineering talent, particularly in software development. Notable openings include "Robotics Software Engineer" [https://careers.intuitive.com/en/jobs/744000127977199/JOB213116/robotics-software-engineer/], "Staff Platform Software Engineer" [https://careers.intuitive.com/en/jobs/744000126359920/JOB215291/staff-platform-software-engineer/], "Sr Software Engineer Navigation" [https://careers.intuitive.com/en/jobs/744000131984809/JOB216049/sr-software-engineer-navigation/], "Senior Embedded Software Engineer" [https://careers.intuitive.com/en/jobs/744000115068337/JOB212956/senior-embedded-software-engineer/], and "Staff Software Engineer" [https://careers.intuitive.com/en/jobs/744000120934767/JOB212566/staff-software-engineer/], predominantly in Sunnyvale, CA. These roles are critical for developing the next generation of their robotic systems, such as the Da Vinci 5 and Ion robotic bronchoscopy [https://intuitive.com/], signaling a strategic investment in core technological advancement.

Beyond engineering, Intuitive Surgical is also hiring for commercial and clinical roles, including "Sr Mgr Commercial Distribution" [https://careers.intuitive.com/en/jobs/744000135521289/JOB216481/sr-mgr-commercial-distribution/] and "da Vinci Clinical Territory Associate" [https://careers.intuitive.com/en/jobs/744000135516156/REF25019N/da-vinci-clinical-territory-associate/]. Other areas with significant openings include Clinical Affairs and Customer Experience and Services, each listing numerous roles [https://careers.intuitive.com/en/career-opportunities/]. The company's expansion of direct operations in Europe further illustrates a global growth strategy [https://intuitive.com/]. There is no information from the provided sources indicating any recent layoffs at Intuitive Surgical.

Intuitive Surgical's consistent and diverse hiring patterns, with over 500 open positions, strongly signal a company in an active growth phase. The emphasis on engineering, particularly in robotics and software, points to a strategy centered on continuous innovation and enhancement of its core product lines. Simultaneously, the recruitment for commercial, clinical, and customer-facing roles suggests an expansion in market reach and client support, reinforcing its global leadership in robotic-assisted surgery and minimally invasive care [https://careers.intuitive.com/en/jobs/744000120934767/JOB212566/staff-software-engineer/].

Leadership

Intuitive Surgical Management and Leadership Team

Intuitive Surgical (intuitive.com) is led by an experienced team dedicated to advancing minimally invasive care careers.intuitive.com/en/get-to-know-us-leadership/. As of July 1, 2025, David J. Rosa is the chief executive officer and a member of the board of directors, following his promotion from President intuitive.com/en-us/about-us/company/leadership/dave-rosa isrg.intuitive.com/news-releases/news-release-details/intuitive-announces-ceo-transition-effective-july-1-2025. Prior to this, Mr. Rosa held a variety of leadership positions within the company intuitive.com/en-us/about-us/company/leadership/dave-rosa.Gary S. Guthart, PhD, transitioned from CEO to executive chair of the Board of Directors in 2025, bringing over 30 years of medical and engineering experience to this role intuitive.com/en-us/about-us/company/leadership/gary-guthart isrg.intuitive.com/news-releases/news-release-details/intuitive-announces-ceo-transition-effective-july-1-2025. The board includes a majority of independent directors, as mandated by NASDAQ, with only the CEO and Executive Chair being non-independent intuitive.com/en-us/about-us/company/legal/governance/board-committees.The C-suite at Intuitive Surgical features several key executives driving various aspects of the business.

Henry L. Charlton serves as executive vice president and chief commercial and marketing officer, responsible for global customer engagement intuitive.com/en-us/about-us/company/leadership/henry-charlton.

Brian E. Miller, Ph.D., is the executive vice president and chief digital officer, overseeing the company's digital business initiatives intuitive.com/en-us/about-us/company/leadership/brian-miller.Myriam J. Curet, MD, FACS, holds the position of executive vice president and chief medical officer, a role she has held since November 2017 intuitive.com/en-us/about-us/company/leadership/myriam-curet. Dr. Curet first joined Intuitive Surgical in 2005 as chief medical advisor and was promoted to senior vice president and chief medical officer in 2014 intuitive.com/en-us/about-us/company/leadership/myriam-curet. Her extensive background includes serving as a clinical professor of surgery at Stanford University intuitive.com/en-us/about-us/company/leadership/myriam-curet.

Financials

Intuitive Surgical Financial Performance, Fundraising, M&A

Intuitive Surgical (Nasdaq: ISRG) is a pioneer and global technology leader in robotic-assisted, minimally invasive surgery, with its headquarters in Sunnyvale, California [https://isrg.intuitive.com/]. The company's financial performance demonstrates consistent growth, with revenue reaching approximately $10.1 billion in 2025, marking a 21% increase from 2024. Research and development spending by Intuitive Surgical exceeded $1 billion in 2025 as the company continues to expand its core capabilities [https://isrg.intuitive.com/static-files/00c12795-0d3a-4d09-b4ed-576424950d48].

Looking at more recent results, Intuitive Surgical reported first quarter 2026 revenue of $2.77 billion, a 23% increase compared to $2.25 billion in the first quarter of 2025. GAAP net income attributable to Intuitive Surgical, Inc. for the first quarter of 2026 was $822 million, or $2.28 per share [https://isrg.intuitive.com/news-releases/news-release-details/intuitive-announces-first-quarter-earnings-7/]. The company also saw its second quarter 2025 revenue increase by 21% to $2.44 billion, up from $2.01 billion in the same period of 2024 [https://isrg.intuitive.com/news-releases/news-release-details/intuitive-announces-second-quarter-earnings-5/].

Intuitive Surgical maintains a strong financial position, evidenced by total assets of $20,111.0 million as of a recent reporting period, which includes current assets like $3,368.0 million in cash and cash equivalents and $2,510.8 million in short-term investments [https://isrg.intuitive.com/static-files/8d536618-2150-41fb-b463-a6d6691d59bd]. The company is a large accelerated filer, indicating its significant market capitalization and financial health [https://isrg.intuitive.com/static-files/d0a136a2-4953-451e-84c7-d792b81c85f8]. While specific funding rounds or acquisitions are not detailed in the provided sources, the consistent revenue growth and substantial investment in research and development underscore Intuitive Surgical's robust financial performance and commitment to innovation in robotic-assisted surgery [https://isrg.intuitive.com/static-files/00c12795-0d3a-4d09-b4ed-576424950d48].

Partnerships

Intuitive Surgical Partnerships, Clients and Vendors

Intuitive Surgical actively cultivates an extensive ecosystem of partnerships, clients, and vendors to advance its robotic-assisted surgery platforms. A significant collaboration includes Siemens Healthineers, with whom Intuitive enhanced scanning integration for its Ion Endoluminal procedures, allowing seamless cone beam CT scans during robotic bronchoscopy [https://isrg.intuitive.com/news-releases/news-release-details/intuitive-and-siemens-healthineers-enhance-scanning-integration]. Another key partnership involves a joint venture with Fosun Pharma to research, develop, manufacture, and sell lung cancer diagnostic and therapeutic tools in China [https://isrg.intuitive.com/news-releases/news-release-details/intuitive-surgical-and-fosun-pharma-establish-joint-venture]. Furthermore, Intuitive collaborated with Ethicon Endo-Surgery, a leader in minimally invasive surgical devices, on various initiatives including training [https://isrg.intuitive.com/news-releases/news-release-details/intuitive-surgical-announces-collaboration-surgical-industry].

Intuitive Surgical works with a wide range of clients, including hospitals and healthcare systems globally. These institutions utilize Intuitive's da Vinci Surgical Systems, with over 11,040 systems placed in hospitals worldwide and over 17.67 million procedures performed to date [https://isrg.intuitive.com/static-files/7bb532d6-7423-43c8-9681-a4787514cd9c].

Intuitive also offers the Accelerated MIS Program (AMP), a flexible, pay-per-use acquisition model designed for hospitals and health systems to access premium robotic system technology without significant upfront costs [https://www.intuitive.com/en-us/-/media/ISI/Intuitive/Pdf/Accelerated-MIS-program-AMP-One-Pager.pdf].

The company emphasizes a comprehensive and integrated ecosystem that supports patients, surgeons, and hospitals [https://isrg.intuitive.com/static-files/996d1dcf-346b-47b7-9806-6c2fa916c906]. This ecosystem extends to various collaborations aimed at expanding access to high-quality, minimally invasive care by partnering with hospitals, healthcare systems, and patient advocacy groups [https://isrg.intuitive.com/static-files/5941e58f-7042-4594-ae87-e9dd032c09a0].

Intuitive is committed to robust supplier quality, establishing stringent controls and rigorous selection, evaluation, and monitoring processes to ensure its partners deliver high-quality, safe, and effective products and services [https://www.intuitive.com/en-us/about-us/company/suppliers].

Events

Intuitive Surgical Event Participations

Intuitive Surgical actively participates in a variety of events, including conferences, trade shows, and educational summits, to engage with healthcare professionals, executives, and investors. The company hosts and attends significant industry gatherings to showcase its robotic surgical technology and foster community within the medical field. These events serve as crucial platforms for networking, education, and sharing advancements in robotic-assisted surgery [https://www.intuitive.com/en-us/about-us/company/events].

Among its key events, Intuitive Surgical hosts the Intuitive 360 Summit, an annual conference designed for executive, clinical, and operational leadership to focus on the development of robotic service lines [https://www.intuitive.com/en-us/healthcare-professionals/hospital-executives/executive-education/executive-events]. They also organize the Asia Executive Summit, which in 2025 will unite hospital executives, surgeons, and care teams to empower healthcare professionals in building high-performing robotic surgery programs [https://info.intuitive.com/AES2025.html]. Furthermore, Intuitive Surgical supports its physician community through events like WIDVS, a flagship gathering for education, mentorship, and community building, featuring workshops and thought leadership panels [https://www.intuitive.com/en-us/healthcare-professionals/surgeons/widvs].

Intuitive Surgical also participates in major financial conferences, such as the 44th Annual J.P. Morgan Healthcare Conference [https://isrg.intuitive.com/events/event-details/intuitive-44th-annual-jp-morgan-healthcare-conference] and the Wells Fargo Healthcare Conference [https://isrg.intuitive.com/events/event-details/intuitive-wells-fargo-healthcare-conference-0]. The company regularly holds investor-focused events, including quarterly earnings conference calls and annual shareholders' meetings, to provide financial updates and engage with stakeholders [https://isrg.intuitive.com/events-and-presentations/].

Beyond large-scale conferences, Intuitive Surgical conducts webinars, such as those focusing on reprocessing steps for da Vinci instruments [https://info.intuitive.com/genesis-training-webinar.html]. They also engage in specialized educational initiatives like the Thoracic Oncology Mobile Experience (TOME), a mobile educational center that showcases transformative lung cancer technologies and robotic solutions to enhance thoracic oncology programs [https://info.intuitive.com/tome/html]. The company also hosts career-focused events for early-in-career development and veterans to recruit talent [https://careers.intuitive.com/en/events/].

Frequently Asked Questions

What is the strategic implication of Intuitive Surgical's substantial hiring for software engineering roles, particularly for Da Vinci 5 and Ion?

Intuitive Surgical's strong hiring for robotics and software engineers, including roles like 'Robotics Software Engineer' and 'Sr Software Engineer Navigation,' indicates a strategic focus on continuous innovation and advancement of its core product lines. This is particularly evident with openings related to the Da Vinci 5 and Ion robotic bronchoscopy systems, signaling investment in the next generation of their robotic surgical systems and expansion in minimally invasive care.

What does the CEO transition from Gary Guthart to David Rosa signify for Intuitive Surgical's leadership strategy?

The transition of Gary S. Guthart, PhD, from CEO to executive chair and David J. Rosa's promotion from President to CEO as of July 1, 2025, suggests a strategic succession planning effort to maintain experienced leadership while fostering new executive direction. Mr. Rosa's long tenure in various leadership roles within the company positions him to continue Intuitive Surgical's trajectory, while Dr. Guthart's continued presence on the board ensures a smooth transition and retention of his extensive medical and engineering expertise.

How is Intuitive Surgical responding to competition from Medtronic's Hugo RAS, especially after its FDA approval?

Intuitive Surgical is responding to competition, such as Medtronic's Hugo RAS, by continuing to innovate its da Vinci and Ion systems, backed by over $1 billion in R&D spending in 2025. While Hugo RAS received FDA approval for urologic procedures in December 2025, directly challenging Intuitive's soft tissue dominance, Intuitive's substantial R&D investment and consistent product advancements aim to maintain its leadership in robotic-assisted surgery.

What is the strategic rationale behind Intuitive Surgical's new Accelerated MIS Program (AMP) acquisition model?

Intuitive Surgical's Accelerated MIS Program (AMP) is a strategic move to expand access to its da Vinci surgical systems by offering a pay-per-use, flexible acquisition model. This program aims to remove financial barriers for hospitals with tighter capital budgets, allowing them to adopt premium robotic technology without significant upfront costs, thereby broadening market reach and increasing system placements.

What does Intuitive Surgical's extensive event participation, including the Intuitive 360 Summit and Asia Executive Summit, reveal about its market strategy?

Intuitive Surgical's active participation in and hosting of events like the Intuitive 360 Summit and Asia Executive Summit indicates a multi-faceted market strategy focused on education, community building, and executive engagement. These events serve to showcase robotic surgical technology, foster adoption and development of robotic service lines, and empower healthcare professionals, reinforcing its leadership and expanding its global footprint.

What is the significance of Intuitive Surgical's joint venture with Fosun Pharma in China?

The joint venture with Fosun Pharma in China is strategically significant as it focuses on researching, developing, manufacturing, and selling lung cancer diagnostic and therapeutic tools. This partnership allows Intuitive Surgical to expand its specialized offerings, particularly for lung cancer care with its Ion robotic bronchoscopy system, into the critical and growing Chinese market.

How does Intuitive Surgical's focus on digital solutions like My Intuitive and My Intuitive+ impact its value proposition?

Intuitive Surgical's investment in digital solutions such as My Intuitive and My Intuitive+ enhances its value proposition by providing integrated support for surgeons, pulmonologists, and care teams. My Intuitive offers clinical data and learning tools, while My Intuitive+ (exclusive to da Vinci 5) provides AI-powered video analysis and real-time collaboration, aiming to optimize care delivery, improve surgical outcomes, and foster program development.

Given Intuitive Surgical's substantial revenue growth and R&D spending, what is the company's financial health outlook?

Intuitive Surgical demonstrates robust financial health, with revenue reaching approximately $10.1 billion in 2025 (a 21% increase from 2024) and $2.77 billion in Q1 2026 (a 23% increase from Q1 2025). Coupled with over $1 billion in R&D spending in 2025 and total assets of $20.1 billion, this performance indicates strong financial stability and a significant commitment to ongoing innovation in robotic-assisted surgery.

How does Intuitive Surgical differentiate itself from competitors like Stryker and Zimmer Biomet in the robotic surgery market?

Intuitive Surgical differentiates itself from competitors like Stryker and Zimmer Biomet by primarily focusing on soft tissue robotic surgery with its da Vinci and Ion systems, while Stryker's Mako system leads in orthopedic robotics and Zimmer Biomet's ROSA system targets neurosurgery and spine procedures. Intuitive's strategy emphasizes broad minimally invasive applications, whereas competitors often specialize in specific surgical niches.

What is the strategic implication of Intuitive Surgical's partnership with Siemens Healthineers for Ion Endoluminal procedures?

The partnership with Siemens Healthineers to enhance scanning integration for Ion Endoluminal procedures signifies Intuitive Surgical's commitment to optimizing workflow and improving diagnostic capabilities within its robotic bronchoscopy system. This collaboration allows for seamless cone beam CT scans during procedures, which directly supports advancing lung cancer care through more precise and integrated minimally invasive biopsies.

What does Intuitive Surgical's consistent and diverse hiring patterns, with hundreds of open positions, imply about its current business phase?

Intuitive Surgical's consistent and diverse hiring patterns, with hundreds of open positions across engineering, commercial, and clinical roles, strongly indicate that the company is in an active growth phase. The demand for talent suggests an ongoing strategy of continuous innovation, expansion of market reach, and enhanced client support for its global leadership in robotic-assisted surgery.

Powered by ForesightIQ · Competitive intelligence from digital exhaust